Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand

MT Newswires Live

04/30

Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.

It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.

RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.

Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.

Its shares rose over 2% in recent trading on Thursday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2631867579"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2631867579\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2631867579?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 08:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631867579","market":"sg","top_or_hot":-1,"title":"Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand","media":"MT Newswires Live","content":"<html><body><p> Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a>, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.</p><p>It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.</p><p>RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.</p><p>Its exclusive distribution partner in <a href=\"https://laohu8.com/S/AN3PL.AU\">Australia and New Zealand</a>, Revolution Surgical, expects to begin the commercial launch within the coming weeks.</p><p>Its shares rose over 2% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-30 08:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a>, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.</p><p>It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.</p><p>RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.</p><p>Its exclusive distribution partner in <a href=\"https://laohu8.com/S/AN3PL.AU\">Australia and New Zealand</a>, Revolution Surgical, expects to begin the commercial launch within the coming weeks.</p><p>Its shares rose over 2% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XAO.AU","symbol_name":"标普/澳交所 普通股指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2631867579","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631867579","pubTimestamp":1777509752,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Avita Medical  said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.Its shares rose over 2% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XAO.AU":"标普/澳交所 普通股指数","AVH.AU":"Avita Therapeutics","XKO.AU":"标普/澳交所 300指数","NZ50G.NZ":"S&P/NZX 50","T10G.NZ":"S&P/NZX 10","XJO.AU":"标普/澳交所 200指数","BK7067":"生物科技","BK7508":"医药生物股","NZ20C.NZ":"S&P/NZX 20"},"translate_title":"阿维塔医疗称伤口护理系统制备方法获得澳大利亚、新西兰监管机构批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NZ50G.NZ":1.5,"T10G.NZ":1.5,"XAO.AU":1.5,"AVH.AU":1,"XJO.AU":1.5,"XKO.AU":1.5,"NZ20C.NZ":1.5},"content_text":"Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.Its shares rose over 2% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}